What is 'proxy access' and how does it affect Cardinal Health shareholders?

Proxy access allows eligible shareholders to nominate their own candidates for the board of directors and have those candidates included in the company's official proxy materials for shareholder votes. For Cardinal Health, this means shareholders meeting specific ownership thresholds (3% for three years) now have a formal mechanism to nominate directors, increasing potential shareholder influence on board composition.

What are the specific ownership and holding period requirements for a shareholder to use proxy access?

A shareholder, or a group of up to 20 shareholders, must have continuously owned at least 3% of Cardinal Health's outstanding common shares for a minimum of three consecutive years to be eligible to nominate directors under the proxy access provision.

How many directors can shareholders nominate through proxy access?

Eligible shareholders can nominate up to the greater of two directors or 20% of the number of directors then serving on Cardinal Health's board. The nominee(s) must also satisfy the requirements outlined in the updated Regulations.

When do these new rules take effect?

The amendments to the Regulations are effective immediately upon adoption, except for the specific change to the advance notice period for business or nominations at an annual meeting, which becomes effective on August 29, 2016. This ensures the notice period for the 2016 annual meeting remains as previously communicated.

CAH 8-K: Corporate Changes

Summary

This 8-K filing from Cardinal Health, Inc. (CAH) on June 30, 2016, announces significant amendments to the company's Restated Code of Regulations, primarily to implement proxy access. This change allows eligible shareholders, owning at least 3% of outstanding common shares for a minimum of three years, to nominate and include director candidates in the company's proxy materials. Specifically, shareholders can nominate up to the greater of two directors or 20% of the board size, provided they meet the stipulated requirements within the Regulations. In addition to introducing proxy access, the amendments also update the advance notice provisions for shareholder nominations and proposals. These changes aim to streamline the process for shareholders wishing to engage directly with the board. The amendments are effective immediately, with a slight delay for one specific provision related to advance notice for the 2016 annual meeting to maintain consistency with prior proxy statements. Investors should note this shift towards greater shareholder participation in board nominations.

Key Highlights

1Cardinal Health adopted amendments to its Code of Regulations to implement proxy access.
2Shareholders owning at least 3% of common stock for three continuous years can now nominate directors.
3Eligible shareholders can nominate up to the greater of two directors or 20% of the board.
4The amendments revise advance notice provisions for shareholder nominations and proposals.
5These changes are intended to enhance shareholder engagement and participation in board composition.
6The amendments are effective immediately, with a minor exception for the 2016 annual meeting notice period.

CARDINAL HEALTH INC 8-K Report, Bylaw Amendment (Jun 30, 2016)

Summary

Key Highlights

Frequently Asked Questions